EEA

DRUG2 trials

Sponsors

The University of Texas Health Science Center at San Antonio

Conditions

Chronic Kidney DiseaseEnd Stage Renal DiseaseSarcopenia

Early Phase 1

Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis

CompletedNCT05705414

The University of Texas Health Science Center at San AntonioEnd Stage Renal Disease

Start: 2024-10-18End: 2026-05-30Updated: 2026-08-26

Sarcopenia in Chronic Kidney Disease (CKD) Patients

Not yet recruitingNCT07437053

The University of Texas Health Science Center at San AntonioChronic Kidney Disease, Sarcopenia

Start: 2026-08-24End: 2027-10-30Target: 20Updated: 2026-08-11